Tyenne 162 mg solution for injection in pre-filled pen

DRUG2 trials

Sponsors

Cardiff University

Conditions

Psoriatic ArthritisRheumatoid Arthritis

Phase 2

DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMMUNE-MEDIATED INFLAMMATORY DISEASES (IMIDS) USING SYSTEMS APPROACHES

WithdrawnCTIS2024-518011-19-00

Cardiff UniversityPsoriatic Arthritis, Rheumatoid Arthritis

Target: 10Updated: 2025-07-14

DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMMUNE-MEDIATED INFLAMMATORY DISEASES (IMIDS) USING SYSTEMS APPROACHES

Not yet recruitingCTIS2024-518011-19-01

Cardiff UniversityPsoriatic Arthritis, Rheumatoid Arthritis

Target: 10Updated: 2025-10-30